View in EDS PDF Full Text

Off-Label Use of First-Line Immunotherapy for Metastatic Renal Cell Carcinoma.

Saved in:
Bibliographic Details
Title: Off-Label Use of First-Line Immunotherapy for Metastatic Renal Cell Carcinoma.
Authors: McManus HD; Department of Medicine, Duke University School of Medicine, Durham, NC. Electronic address: hannah.mcmanus@duke.edu., Long JB; Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT; Department of Internal Medicine, Yale School of Medicine, New Haven, CT., Westvold SJ; Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT; Department of Internal Medicine, Yale School of Medicine, New Haven, CT., Leapman MS; Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT; Department of Urology, Yale School of Medicine, New Haven, CT; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT., Hurwitz ME; Department of Internal Medicine, Yale School of Medicine, New Haven, CT., Mitchell AP; Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Pollack CE; Department of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD and Johns Hopkins School of Nursing, Baltimore, MD., Gross CP; Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT; Department of Internal Medicine, Yale School of Medicine, New Haven, CT; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT., Dinan MA; Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT.
Source: Clinical genitourinary cancer [Clin Genitourin Cancer] 2025 Jun; Vol. 23 (3), pp. 102330. Date of Electronic Publication: 2025 Mar 15.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40186898
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Off-Label Use of First-Line Immunotherapy for Metastatic Renal Cell Carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22McManus+HD%22">McManus HD</searchLink>; Department of Medicine, Duke University School of Medicine, Durham, NC. Electronic address: hannah.mcmanus@duke.edu.<br /><searchLink fieldCode="AU" term="%22Long+JB%22">Long JB</searchLink>; Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT; Department of Internal Medicine, Yale School of Medicine, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Westvold+SJ%22">Westvold SJ</searchLink>; Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT; Department of Internal Medicine, Yale School of Medicine, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Leapman+MS%22">Leapman MS</searchLink>; Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT; Department of Urology, Yale School of Medicine, New Haven, CT; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Hurwitz+ME%22">Hurwitz ME</searchLink>; Department of Internal Medicine, Yale School of Medicine, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Mitchell+AP%22">Mitchell AP</searchLink>; Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Pollack+CE%22">Pollack CE</searchLink>; Department of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD and Johns Hopkins School of Nursing, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Gross+CP%22">Gross CP</searchLink>; Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT; Department of Internal Medicine, Yale School of Medicine, New Haven, CT; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Dinan+MA%22">Dinan MA</searchLink>; Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101260955%22">Clinical genitourinary cancer</searchLink> [Clin Genitourin Cancer] 2025 Jun; Vol. 23 (3), pp. 102330. <i>Date of Electronic Publication: </i>2025 Mar 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101260955 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0682 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215587673%22">15587673 </searchLink><i>NLM ISO Abbreviation: </i>Clin Genitourin Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40186898
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.clgc.2025.102330
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 102330
    Titles:
      – TitleFull: Off-Label Use of First-Line Immunotherapy for Metastatic Renal Cell Carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: McManus HD
      – PersonEntity:
          Name:
            NameFull: Long JB
      – PersonEntity:
          Name:
            NameFull: Westvold SJ
      – PersonEntity:
          Name:
            NameFull: Leapman MS
      – PersonEntity:
          Name:
            NameFull: Hurwitz ME
      – PersonEntity:
          Name:
            NameFull: Mitchell AP
      – PersonEntity:
          Name:
            NameFull: Pollack CE
      – PersonEntity:
          Name:
            NameFull: Gross CP
      – PersonEntity:
          Name:
            NameFull: Dinan MA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2025 Jun
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1938-0682
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Clinical genitourinary cancer
              Type: main
ResultId 1